Van Hulzen Asset Management LLC Boosts Stock Position in Merit Medical Systems, Inc. $MMSI

Van Hulzen Asset Management LLC raised its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 25.0% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 28,877 shares of the medical instruments supplier’s stock after buying an additional 5,778 shares during the period. Van Hulzen Asset Management LLC’s holdings in Merit Medical Systems were worth $2,002,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. AQR Capital Management LLC increased its stake in Merit Medical Systems by 7.3% in the 1st quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock valued at $1,730,000 after purchasing an additional 1,114 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Merit Medical Systems by 16.9% during the first quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock worth $76,039,000 after purchasing an additional 103,878 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Merit Medical Systems by 745.9% in the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after purchasing an additional 813 shares during the last quarter. First Trust Advisors LP increased its position in shares of Merit Medical Systems by 24.8% in the second quarter. First Trust Advisors LP now owns 59,215 shares of the medical instruments supplier’s stock valued at $5,535,000 after buying an additional 11,770 shares in the last quarter. Finally, Cerity Partners LLC raised its stake in shares of Merit Medical Systems by 9.1% during the 2nd quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock worth $282,000 after buying an additional 251 shares during the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems Stock Performance

Shares of MMSI opened at $87.19 on Thursday. The firm has a fifty day moving average of $82.95 and a 200-day moving average of $73.29. The company has a market cap of $5.21 billion, a price-to-earnings ratio of 36.03, a price-to-earnings-growth ratio of 2.18 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts anticipate that Merit Medical Systems, Inc. will post 3.84 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on MMSI. Robert W. Baird set a $98.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 31st. Barrington Research set a $114.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Bank of America increased their target price on Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Weiss Ratings upgraded shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 18th. Finally, Wells Fargo & Company increased their price target on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $100.00.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.